Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

thinkemotive

National Institute for Health and Care Excellence NICE logo

NICE backtracks on prostate cancer drug enzalutamide

Says Astellas and Medivation's Xtandi can be used within the NHS in England and Wales

Apple snaps up medical experts

Technology giant Apple continues its medical tech executive recruitment drive

- PMLiVE

GSK clear to launch COPD hope Anoro in Europe

Strengthens respiratory platform ahead of patent expiry for Advair/Seretide

- PMLiVE

St Ives buys Hive

Says healthcare consultancy complements the company’s existing offering

- PMLiVE

Lundbeck agrees $658m deal to buy Chelsea Therapeutics

Acquisition boosts Danish firm's neurology profile and presence in US

- PMLiVE

AZ starts pivotal trials of lung cancer immunotherapy

Moves MEDI4736 into phase III testing for non-small cell lung cancer

- PMLiVE

Boehringer unveils large study in stroke prevention

Will assess benefits of Pradaxa

EU flag

AbbVie’s hep C combo gets priority review in Europe

EMA to fast track drug for use in hard-to-treat genotype 1 strain of HCV

Novartis building

Novartis plans filings for acromegaly candidate

Could add to Signifor’s indications

- PMLiVE

Grunenthal to market MSD’s pain drug

Acquires rights to Arcoxia in several European countries

GW hires Pfizer’s Kenneth Sommerville

Appointed VP clinical research at company specialising in cannabinoids

- PMLiVE

Roska rebrands as PulseCX

New identity reflects the healthcare advertising firm’s focus on the customer experience

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links